Table 6– Comparison of relevant haplotypes encompassing SFTPD, SFTPA1, SFTPA2 and MBL2 between pneumococcal community-acquired pneumonia (P-CAP) patients and controls

Haplotype	P-CAP^#	Controls^¶	OR (CI 95%)	p-value⁺
XA	48 (16.1)	388 (21.2)	0.72 (0.51–0.99)	0.053
*6A²*	158 (53.0)	1088 (59.4)	0.60 (0.57–0.99)	0.042
*1A⁰*	150 (50.3)	1069 (58.4)	0.72 (0.57–0.93)	0.010
*6A²-XA*	23 (7.7)	205 (11.2)	0.66 (0.42–1.04)	0.085
*1A⁰-XA*	21 (7.0)	207 (11.3)	0.60 (0.37–0.95)	0.033
*6A²-1A⁰*	131 (44.0)	940 (51.5)	0.74 (0.58–0.95)	0.021
*6A²-1A⁰ -XA*	18 (6.0)	185 (10.1)	0.57 (0.35–0.94)	0.033
*C-6A²-1A⁰-XA*	3 (1.0)	80 (4.4)	0.22 (0.07–0.71)	0.005

Data are presented as the n chromosomes (%), unless otherwise stated. Only relevant haplotypes are shown. MBL2: mannose-binding lectin 2 gene. ^#: n=298; ^¶: n=1832; ⁺: uncorrected for the bivariate comparison of haplotypes.